Synbiotic loaded chitosan-Ca-alginate microparticles reduces inflammation in the TNBS model of rat colitis

International Journal of Pharmaceutics

Volumn 527, Issue 1-2, 2017, Pages 126-134

  Ivanovska, Tanja Petreska ^a   Mladenovska, Kristina ^a   Zhivikj, Zoran ^a   Pavlova, Maja Jurhar ^b   Gjurovski, Ivica ^c   Ristoski, Trpe ^c   Petrushevska Tozi, Lidija ^a  

^a SS Cyril and Methodius University Faculty of Pharmacy   (Macedonia)

^b SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

^c SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

Author keywords

Chitosan Ca alginate microparticles; Lactobacillus casei 01; Oligofructose enriched inulin; Rat colitis; Trinitrobenzenesulphonic acid

Indexed keywords

CALCIUM ALGINATE; CHITOSAN; MYELOPEROXIDASE; SYNBIOTIC AGENT; ALGINIC ACID; GLUCURONIC ACID; HEXURONIC ACID; PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL TRANSLOCATION; BODY WEIGHT; CLINICAL FEATURE; CONTROLLED STUDY; DEACETYLATION; EXPERIMENTAL COLITIS; FEMALE; FOOD INTAKE; HISTOPATHOLOGY; LACTIC ACID BACTERIUM; LACTOBACILLUS CASEI; MESENTERY LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; COLITIS; INFLAMMATION; WISTAR RAT;

ALGINATES; ANIMALS; CHITOSAN; COLITIS; FEMALE; GLUCURONIC ACID; HEXURONIC ACIDS; INFLAMMATION; PROBIOTICS; RATS; RATS, WISTAR; SYNBIOTICS;

EID: 85019766282     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2017.05.049     Document Type: Article

References (40)

1. Šimůnek, J., Brandysová, V., Koppová, I., Šimůnek Jr., The antimicrobial action of chitosan, low molar mass chitosan, and chitooligosaccharides on human colonic bacteria. Folia Microbiol. 57 (2012), 341–345.
2. Andoh, A., Kuzuoka, H., Tsujikawa, T., Nakamura, S., Hirai, F., Suzuki, Y., Matsui, T., Fujiyama, Y., Matsumoto, T., Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease. J. Gastroenterol. 47 (2012), 1298–1307.
3. Andrews, C.N., Griffiths, T.A., Kaufman, J., Vergnolle, N., Surette, M.G., Rioux, K.P., Mesalazine (5-aminosalicylic acid) alters fecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther. 34 (2011), 374–383.
4. Antoniou, E., Margonis, G.A., Angelou, A., Pikouli, A., Argiri, P., Karavokyros, I., Papalois, A., Pikoulis, E., The TNBS-induced colitis animal model: an overview. Ann. Med. Surg. 11 (2016), 9–15.
5. Bertazzoni Minelli, S.E., Benini, A., Relationship between number of bacteria and their probiotic effects. Microb. Ecol. Health Dis. 20 (2008), 180–183.
6. Brenna, Ø., Furnes, M.W., Drozdov, I., Granlund, A.B., Flatberg, A., Sandvik, A.K., Zwiggelaar, R.T.M., Mårvik, R., Nordrum, I.S., Kidd, M., Gustafsson, B.I., Relevance of TNBS-colitis in rats: a methodological study with endoscopic, histologic and transcriptomic characterization and correlation to IBD. PLoS One, 8(1), 2013, e54543.
7. Cammarota, G., Ianiro, G., Cianci, R., Bibbò, S., Gasbarrini, A., Currò, D., The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy. Pharmacol. Ther. 149 (2015), 191–212.
8. Cook, M.T., Tzortzis, G., Charalampopoulos, D., Khutoryanskiy, V.V., Microencapsulation of probiotics for gastrointestinal delivery. J. Control. Rel. 162 (2012), 56–67.
9. Daniel, C., Poiret, S., Goudercourt, D., Dennin, V., Leyer, G., Pot, B., Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model. Appl. Environ. Microbiol. 72 (2006), 5799–5805.
10. Foligné, B., Parayre, S., Cheddani, R., Famelart, M.-H., Madec, M.-N., Plé, C., Breton, J., Jan, G., Deutsch, S.-M., Immunomodulation properties of multi-species fermented milks. Food Microbiol. 53 (2016), 60–69.
11. Govender, M., Choonara, Y.E., Kumar, P., du Toit, L.C., van Vuuren, S., Pillay, V., A review of the advancements in probiotic delivery: conventional vs. non-conventional formulations for intestinal flora supplementation. AAPS Pharm. SciTech. 15 (2014), 29–43.
12. Goy, R.C., Morais, S.T.B., Assis, O.B.G., Evaluation of the antimicrobial activity of chitosan and its quaternized derivative on E. coli and S. aureus growth. Braz. J. Pharmacogn. 26 (2016), 122–127.
13. Herias, M.V., Koninkx, J.F.J.G., Vos, J.G., Huis in't Veld, J.H.J., van Dijk, J.E., Probiotic effects of Lactobacillus casei on DSS-induced ulcerative colitis in mice. Int. J. Food Microbiol. 103 (2005), 143–155.
14. Kawahara, M., Nemoto, M., Nakata, T., Kondo, S., Takahashi, H., Kimura, B., Kuda, T., Anti-inflammatory properties of fermented soy milk with Lactococcus lactis S-SU2 in murine macrophage RAW264.7 cells and DSS-induced IBD model mice. Int. Immunopharmacol. 26 (2015), 295–303.
15. Korada, S.K., Yarla, N.S., Bishayee, A., Aliev, G., Aruna Lakshmi, K., Arunasree, M.K., Dananajaya, B.L., Mishra, V., Can probiotics cure inflammatory bowel diseases?. Curr. Pharm. Des. 22 (2016), 904–917.
16. Krawisz, J.E., Sharon, P., Stenson, W.F., Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87 (1984), 1344–1350.
17. Kumar Thakur, B., Saha, P., Banik, G., Rani Saha, D., Grover, S., Kumar Batish, V., Das, S., Live and heat-killed probiotic Lactobacillus casei Lbs2 protects from experimental colitis through Toll-like receptor 2-dependent induction of T-regulatory response. Int. Immunopharmacol. 36 (2016), 39–50.
18. Lamprecht, A., Schafer, U., Lehr, C.M., Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharm. Res. 18 (2001), 788–793.
19. Lee, L.C., Tomita, S., Kleerebezem, M., Bron, P.A., The guest for probiotic effector molecules−unraveling strain specificity at the molecular level. Pharm. Res. 69 (2013), 61–74.
20. Llopis, M., Antolin, M., Guarner, F., Salas, A., Malagelada, J.-R., Mucosal colonisation with Lactobacillus casei mitigates barrier injury induced by exposure to trinitrobenzene sulphonic acid. Gut 54 (2005), 955–959.
21. Matsuoka, K., Kanai, T., The gut microbiota and inflammatory bowel disease. Semin. Immunopathol. 37 (2015), 47–55.
22. Minihane, A.M., Vinoy, S., Russell, W.R., Baka, A., Roche, H.M., Tuohy, K.M., Teeling, J.L., Blaak, E.E., Fenech, M., Vauzour, D., McArdle, H.J., Kremer, B.H.A., Sterkman, L., Vafeiadou, K., Benedetti, M.M., Williams, C.M., Calder, P.C., Low-grade inflammation, diet composition and health: current research evidence and its translation. Br. J. Nutr. 114:7 (2015), 999–1012.
23. Morris, G.P., Beck, P.L., Herridge, M.S., Depew, W.T., Szewczuk, M.R., Wallace, J.L., Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96 (1989), 795–803.
24. Nell, S., Suerbaum, S., Josenhans, C., The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat. Rev. Microbiol. 8 (2010), 564–577.
25. Osman, N., Adawi, D., Molin, G., Ahrne, S., Berggren, A., Jeppsson, B., Bifidobacterium infantis strains with and without a combination of oligofructose and inulin (OFI) attenuate inflammation in DSS-induced colitis in rats. BMC Gastroenterol., 6, 2006, 31.
26. Peran, L., Camuesco, D., Comalada, M., Nieto, A., Concha, A., Diaz-Ropero, M.P., Olivares, M., Xaus, J., Zarzuelo, A., Galvez, J., Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis. World J. Gastroenterol. 11 (2005), 5185–5192.
27. Peran, L., Camuesco, D., Comalada, M., Bailon, E., Henriksson, A., Xaus, J., Zarzuelo, A., Galvez, J., A comparative study of the preventive effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis. J. Appl. Microbiol. 103 (2007), 836–844.
28. Petreska Ivanovska, Т., Petrushevska-Tozi, L., Grozdanov, A., Petkovska, R., Hadjieva, J., Popovski, E., Stafilov, T., Mladenovska, K., From optimization of synbiotic microparticles prepared by spray-drying to development of new functional carrot juice. Chem. Ind. Chem. Eng. Q. 20 (2014), 549–564.
29. Petreska Ivanovska, Т., Zhivikj, Z., Mladenovska, K., Petrushevska-Tozi, L., Influence of oligofructose-enriched inulin on survival of microencapsulated Lactobacillus casei 01 and adhesive properties of synbiotic microparticles. Mac. Pharm. Bull. 61 (2015), 35–43.
30. Pigneur, B., Sokol, H., Fecal microbiota transplantation in inflammatory bowel disease: the quest for the Holy Grail. Mucosal Immunol. 9 (2016), 1360–1365.
31. Säemann, M.D., Böhmig, G.A., Österreicher, C.H., Burtscher, H., Parolini, O., Diakos, C., Stöckl, J., Hörl, W.H., Zlabinger, G.J., Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB J. 14 (2000), 2380–2382.
32. Santiago, C., Pagan, B., Isidro, A., Appleyard, C.B., Prolonged chronic inflammation progresses to dysplasia in a novel rat model of colitis-associated colon cancer. Cancer Res. 67 (2007), 10766–10773.
33. Satish Kumar, C.S.V., Kondal Reddy, K., Gopala Reddy, A., Vinoth, A., Sudha Rani Chowdary, C.H., Boobalan, G., Rao, G.S., Protective effect of Lactobacillus plantarum 21, a probiotic on trinitrobenzenesulfonic acid-induced ulcerative colitis in rats. Int. Immunopharmacol. 25 (2015), 504–510.
34. Segain, J.P., Raingeard de la Blétière, D., Bourreille, A., Leray, V., Gervois, N., Rosales, C., Ferrier, L., Bonnet, C., Blottiere, H.M., Galmiche, J.P., Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut 47 (2000), 397–403.
35. Shen, J., Zuo, Z.-X., Mao, A.-P., Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials. Inflamm. Bowel Dis. 20 (2014), 21–35.
36. Solanki, H.K., Shah, D.A., Formulation optimization and evaluation of probiotic Lactobacillus sporogenes-loaded sodium alginate with carboxymethyl cellulose mucoadhesive beads using design expert software. J. Food Process., 2016, 1–14 ID 6041671.
37. Tan, J., McKenzie, C., Potamitis, M., Thornburn, A.N., Mackay, C.R., Macia, L., The role of short-chain fatty acids in health and disease. Adv. Immunol. 121 (2014), 91–119.
38. Verna, E.C., Lucak, S., Use of probiotics in gastrointestinal disorders: what to recommend?. Ther. Adv. Gastroenterol. 3 (2010), 307–319.
39. Videla, S., Vilaseca, J., Antolín, M., García-Lafuente, A., Guarner, F., Crespo, E., Casalots, J., Salas, A., Malagelada, J.R., Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat. Am. J. Gastroenterol. 96 (2001), 1486–1493.
40. Viladomiu, M., Hontecillas, R., Yuan, L., Lu, P., Bassaganya-Riera, J., Nutritional protective mechanisms against gut inflammation. J. Nutr. Biochem. 24 (2013), 929–939.